Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lilit Garibyan, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
Harvard Medical School, Boston, MAMD06/2009Medicine
Harvard Medical School/Harvard University, Cambridge, MAPhD11/2007Experimental Pathology/Immunology
Harvard Medical School/MGH, Boston, MA07/2013Dermatology Residency
UCLA, Los Angeles, CABS09/2001Microbiology and Molecular Genetics

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Garibyan L, Moradi Tuchayi S, Wang Y, Khodorova A, Stemmer-Rachamimov A, Purschke M, Osseiran S, Evans CL, Mao J, Strichartz G, Anderson RR. Neural Selective Cryoneurolysis with Ice Slurry Injection in a Rat Model. Anesthesiology. 2020 Jul; 133(1):185-194. PMID: 31977524.
    Citations:    
  2. Moradi Tuchayi S, Tam J, Wojtkiewicz GR, Kawa NI, Javorsky E, Anderson RR, Garibyan L. Injectable slurry for selective destruction of neck adipose tissue in New Zealand obese mouse model. Sleep Breath. 2020 May 30. PMID: 32474829.
    Citations:    
  3. Garibyan L, Moradi Tuchayi S, Javorsky E, Farinelli WA, Wang Y, Purschke M, Tam J, Ni P, Lian CG, Anderson RR. Subcutaneous Fat Reduction with Injected Ice Slurry. Plast Reconstr Surg. 2020 04; 145(4):725e-733e. PMID: 32221206.
    Citations:    
  4. Garibyan L, Moradi Tuchayi S, Javorsky E, Farinelli WA, Wang Y, Purschke M, Tam J, Ni P, Lian CG, Anderson RR. Subcutaneous Fat Reduction with Injected Ice Slurry. Plast Reconstr Surg. 2020 Jan 07. PMID: 31917745.
    Citations:    
  5. Rosen J, Darwin E, Tuchayi SM, Garibyan L, Yosipovitch G. Skin changes and manifestations associated with the treatment of obesity. J Am Acad Dermatol. 2019 Nov; 81(5):1059-1069. PMID: 31610858.
    Citations:    
  6. Kawa N, Lee KC, Anderson RR, Garibyan L. ONYCHOMYCOSIS: A Review of New and Emerging Topical and Device-based Treatments. J Clin Aesthet Dermatol. 2019 Oct; 12(10):29-34. PMID: 32038746.
    Citations:    
  7. Moradi Tuchayi S, Garibyan L, Lee KC. Successful treatment of multinucleate cell angiohistiocytoma with fractionated ablative CO2 laser. JAAD Case Rep. 2019 Apr; 5(4):297-299. PMID: 30963081.
    Citations:    
  8. Xu S, Xu RS, Breslin J, Raff AB, Garibyan L, Sunshine JC, Ju WD. Professional medical associations and the opportunity to promote breakthrough biomedical innovation. Drug Discov Today. 2018 08; 23(8):1453-1456. PMID: 29391260.
    Citations:    Fields:    Translation:Humans
  9. Garibyan L, Anderson RR. Increasing Clinical Faculty Engagement in Problem-Driven Research: The "Magic Wand" Initiative at Massachusetts General Hospital. JAMA Dermatol. 2017 05 01; 153(5):375-376. PMID: 28252677.
    Citations: 1     Fields:    Translation:Humans
  10. Jabara HH, Lee JJ, Janssen E, Ullas S, Liadaki K, Garibyan L, Benson H, Sannikova T, Bram R, Hammarstrom L, Cruz AC, Siegel R, Manis J, Malley R, Geha RS. Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice. J Allergy Clin Immunol. 2017 Apr; 139(4):1293-1301.e4. PMID: 27609654.
    Citations:    Fields:    Translation:HumansAnimalsCells
  11. Lin RL, Garibyan L, Kimball AB, Drake LA. Systemic causes of hair loss. Ann Med. 2016 09; 48(6):393-402. PMID: 27145919.
    Citations: 1     Fields:    Translation:Humans
  12. Bae GH, Nambudiri VE, Garibyan L, Sanford S, Huang SJ. Topical Steroid Therapy Educational Video for Eczema. Dermatitis. 2016 May-Jun; 27(3):157-8. PMID: 27172318.
    Citations:    Fields:    
  13. Vedak P, St John J, Watson A, Garibyan L, Mihm MC, Nazarian RM, Levins PC, Cetrulo CL, Schalock P, Kroshinsky D. Delayed type IV hypersensitivity reaction to porcine acellular dermal matrix masquerading as infection resulting in multiple debridements. Hernia. 2017 06; 21(3):489-492. PMID: 26693715.
    Citations:    Fields:    Translation:HumansAnimals
  14. Garibyan L, Cornelissen L, Sipprell W, Pruessner J, Elmariah S, Luo T, Lerner EA, Jung Y, Evans C, Zurakowski D, Berde CB, Rox Anderson R. Transient Alterations of Cutaneous Sensory Nerve Function by Noninvasive Cryolipolysis. J Invest Dermatol. 2015 Nov; 135(11):2623-2631. PMID: 26099028.
    Citations: 2     Fields:    Translation:HumansCells
  15. Ray Jalian H, Tam J, Vuong LN, Fisher J, Garibyan L, Mihm MC, Zurakowski D, Evans CL, Rox Anderson R. Selective Cryolysis of Sebaceous Glands. J Invest Dermatol. 2015 Sep; 135(9):2173-2180. PMID: 25860384.
    Citations: 2     Fields:    Translation:HumansAnimalsCTClinical Trials
  16. Jalian HR, Avram MM, Garibyan L, Mihm MC, Anderson RR. Paradoxical adipose hyperplasia after cryolipolysis. JAMA Dermatol. 2014 Mar; 150(3):317-9. PMID: 24382640.
    Citations: 8     Fields:    Translation:Humans
  17. Garibyan L, Sipprell WH, Jalian HR, Sakamoto FH, Avram M, Anderson RR. Three-dimensional volumetric quantification of fat loss following cryolipolysis. Lasers Surg Med. 2014 Feb; 46(2):75-80. PMID: 24535759.
    Citations: 8     Fields:    Translation:Humans
  18. Garibyan L, Cotter SE, Hansen JL, Noell C, Dorosario A, O'Farrell DA, Devlin PM, Wang LC. Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy. Cancer J. 2013 Jul-Aug; 19(4):283-7. PMID: 23867506.
    Citations: 4     Fields:    Translation:Humans
  19. Le LP, Garibyan L, Lara D, Finberg KE, Iafrate AJ, Duncan LM, Kay J, Nazarian RM. Fibrosis-associated single-nucleotide polymorphisms in TGFB1 and CAV1 are not associated with the development of nephrogenic systemic fibrosis. Am J Dermatopathol. 2013 May; 35(3):351-6. PMID: 23051628.
    Citations: 1     Fields:    Translation:Humans
  20. Garibyan L, Avashia N. Polymerase chain reaction. J Invest Dermatol. 2013 Mar; 133(3):1-4. PMID: 23399825.
    Citations: 9     Fields:    Translation:HumansAnimals
  21. Garibyan L, Rheingold CG, Lerner EA. Understanding the pathophysiology of itch. Dermatol Ther. 2013 Mar-Apr; 26(2):84-91. PMID: 23551365.
    Citations: 6     Fields:    Translation:Humans
  22. Garibyan L, Chiou AS, Elmariah SB. Advanced aging skin and itch: addressing an unmet need. Dermatol Ther. 2013 Mar-Apr; 26(2):92-103. PMID: 23551366.
    Citations: 4     Fields:    Translation:Humans
  23. Alloo A, Garibyan L, LeBoeuf N, Lin G, Werchniak A, Hodi FS, Flaherty KT, Lawrence DP, Lin JY. Photodynamic therapy for multiple eruptive keratoacanthomas associated with vemurafenib treatment for metastatic melanoma. Arch Dermatol. 2012 Mar; 148(3):363-6. PMID: 22431777.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  24. Ozcan E, Rauter I, Garibyan L, Dillon SR, Geha RS. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation. J Allergy Clin Immunol. 2011 Sep; 128(3):601-9.e1-4. PMID: 21741080.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  25. Lee JJ, Jabara HH, Garibyan L, Rauter I, Sannikova T, Dillon SR, Bram R, Geha RS. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. J Allergy Clin Immunol. 2010 Dec; 126(6):1234-41.e2. PMID: 20889194.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  26. Garibyan L, Fisher DE. How sunlight causes melanoma. Curr Oncol Rep. 2010 Sep; 12(5):319-26. PMID: 20623386.
    Citations: 23     Fields:    Translation:Humans
  27. Stebbins WG, Garibyan L, Sober AJ. Sentinel lymph node biopsy and melanoma: 2010 update Part I. J Am Acad Dermatol. 2010 May; 62(5):723-34; quiz 735-6. PMID: 20398810.
    Citations: 3     Fields:    Translation:Humans
  28. Stebbins WG, Garibyan L, Sober AJ. Sentinel lymph node biopsy and melanoma: 2010 update Part II. J Am Acad Dermatol. 2010 May; 62(5):737-48;quiz 749-50. PMID: 20398811.
    Citations: 3     Fields:    Translation:Humans
  29. Lee JJ, Rauter I, Garibyan L, Ozcan E, Sannikova T, Dillon SR, Cruz AC, Siegel RM, Bram R, Jabara H, Geha RS. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Blood. 2009 Sep 10; 114(11):2254-62. PMID: 19605846.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  30. Ozcan E, Garibyan L, Lee JJ, Bram RJ, Lam KP, Geha RS. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells. J Allergy Clin Immunol. 2009 Jun; 123(6):1277-86.e5. PMID: 19427685.
    Citations: 18     Fields:    Translation:AnimalsCells
  31. He R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS. TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc Natl Acad Sci U S A. 2008 Aug 19; 105(33):11875-80. PMID: 18711124.
    Citations: 85     Fields:    Translation:AnimalsCells
  32. Castigli E, Wilson SA, Elkhal A, Ozcan E, Garibyan L, Geha RS. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation. J Allergy Clin Immunol. 2007 Oct; 120(4):885-91. PMID: 17689597.
    Citations: 28     Fields:    Translation:AnimalsCells
  33. Garibyan L, Lobito AA, Siegel RM, Call ME, Wucherpfennig KW, Geha RS. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). J Clin Invest. 2007 Jun; 117(6):1550-7. PMID: 17492055.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  34. Castigli E, Wilson S, Garibyan L, Rachid R, Bonilla F, Schneider L, Morra M, Curran J, Geha R. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet. 2007 Apr; 39(4):430-1. PMID: 17392798.
    Citations: 13     Fields:    Translation:Humans
  35. Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005 Aug; 37(8):829-34. PMID: 16007086.
    Citations: 172     Fields:    Translation:HumansCells
  36. Lenahan C, Garibyan L, Pories S. The role of tumor markers in breast cancer management. Curr Surg. 2004 Nov-Dec; 61(6):532-7. PMID: 15590016.
    Citations:    Fields:    Translation:Humans
  37. Garibyan L, Lenahan C, Pories S. Metalloproteinases: promising tumor markers for breast cancer management. Curr Surg. 2004 May-Jun; 61(3):255-9. PMID: 15165762.
    Citations: 1     Fields:    
  38. Kim M, Wolff E, Huang T, Garibyan L, Earl AM, Battista JR, Miller JH. Developing a genetic system in Deinococcus radiodurans for analyzing mutations. Genetics. 2004 Feb; 166(2):661-8. PMID: 15020457.
    Citations: 12     Fields:    Translation:Cells
  39. Garibyan L, Huang T, Kim M, Wolff E, Nguyen A, Nguyen T, Diep A, Hu K, Iverson A, Yang H, Miller JH. Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair (Amst). 2003 May 13; 2(5):593-608. PMID: 12713816.
    Citations: 95     Fields:    Translation:Cells
  40. Miller JH, Funchain P, Clendenin W, Huang T, Nguyen A, Wolff E, Yeung A, Chiang JH, Garibyan L, Slupska MM, Yang H. Escherichia coli strains (ndk) lacking nucleoside diphosphate kinase are powerful mutators for base substitutions and frameshifts in mismatch-repair-deficient strains. Genetics. 2002 Sep; 162(1):5-13. PMID: 12242219.
    Citations: 34     Fields:    Translation:Cells
  41. Lukac DM, Garibyan L, Kirshner JR, Palmeri D, Ganem D. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters. J Virol. 2001 Aug; 75(15):6786-99. PMID: 11435557.
    Citations: 93     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Garibyan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (261)
Explore
_
Co-Authors (47)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.